Could cutting one amino acid help fight stomach cancer?
NCT ID NCT07537348
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 3-day low-leucine diet can make chemotherapy and immunotherapy work better for people with advanced stomach cancer. Researchers believe the diet may activate immune cells in the tumor. The trial involves 73 participants and will measure tumor shrinkage and survival rates.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- leucine-restricted diet
- What this could lead to
- If it works, this diet could boost the effectiveness of standard cancer treatments, potentially improving survival rates for people with advanced gastric cancer.
- What could go wrong
- This is a small, early-phase trial with only 73 participants. The diet is short-term and may not be feasible for all patients. It is not a cure, and the benefits are uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED GASTRIC CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Qilu Hospital of Shandong University
RECRUITINGJinan, Shandong, 250012, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Acupuncture with a jolt: could needles shield nerves from chemo?
- Real-World check: does adding nivolumab to chemo help stomach cancer patients?
- Fasting during immunotherapy: a new way to boost treatment?
- New drug combo shows promise for tough stomach cancers
- New injection could spare cancer patients from repeated belly drains
- Cancer combo trial halted early: what we learned